19Feb 2020


  • Assistant Professor Department of Biochemistry, MNR Medical College & Hospital, Sangareddy, Telangana, India.
  • Professor & Head Department of Biochemistry, Father Muller Medical College, Mangalore, Karnataka, India.
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Introduction: Smoking is most common among the men aged 15 and above accounting for 51% of the population. The rate at which the adolescent boys use tobacco is 18% globally [GHO, WHO]. In India, an estimated 82.3% males with COPD are smokers. Oxidative effect via free radical generation in smokers has been widely investigated, as it causes the lipid peroxidation, damage to tissues primarily Lung apart from the cardiac diseases. Objective(s) of Study: To estimate the serum levels of Adenosine Deaminase (ADA), Malondialdehyde (MDA), advanced oxidation protein products (AOPP) in smokers, & correlate with Spirometric changes in them. Material and Method: This is a crossectional observational analytical study conducted for a duration of six months at a Medical College Hospital in Mangalore city. A total number of eighty healthy individuals who visited medicine opd were included in this study. Out of these subjects, forty were smokers and other forty nonsmokers. Results: The results were analyzed in the SPSS-23version. A significnat high level of serum MDA, AOPP and low levels of ADA was observed in smokers when compred to non-smokers. Spirometric analysis showed statistical significant decrease in FEV1 (58.5?12%) in smokers. A significant inverse relation of the MDA, AOPP with Spirometric changes & positive relation of ADA levels with spirometry was also observed. Discussion & Conclusion: From this study, it is clear that the smokers are at a high risk of pulmonary diseases. The utility of these parameters as markers for the oxidative damage and variation in lung function test may be a useful tool in educating smokers regarding the ill effects with possible health derangement & urge them to quit smoking.

  1. Moussa SB, Sfaxi I, Tabka Z, Saad HB, Rouatbi S. Oxidative stress and lung function profiles of male smokers free from COPD compared to those with COPD: a case-control study. Libyan J Med. 2014;9:23873.
  2. Jindal SK, Aggarwal AN, Chaudhry K, Chhabra SK, D?Souza GA, Gupta D, et al. Tobacco smoking in India: prevalence, quit-rates and respiratory morbidity. Indian J Chest Dis Allied Sci. 2006;48(1):37?42.
  3. Ozguner F, Koyu A, Cesur G. Active smoking causes oxidative stress and decreases blood melatonin levels. Toxicol Ind Health. 2005;21(1?2):21?6.
  4. Lykkesfeldt J. Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking. Clin Chim Acta. 2007;380(1):50?8.
  5. Kaneda H, Taguchi J, Ogasawara K, Aizawa T, Ohno M. Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis. 2002;162(1):221?5.
  6. WHO | Tobacco. [cited 2016 Jan 10]; Available from: http://www.who.int/mediacentre/factsheets/fs339/en/
  7. Gohe M, Sirajwala H, Kalaria T, Kamariya C. Original Research Article a Study of Serum Adenosine Deaminase Level in Patients With Type 2 Diabetes Mellitus and Its Correlation With Glycemic Control. Int J Med apllied Sci. 2013;2(3):259?67.
  8. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist S, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006;28(3):523?32.
  9. Anderstam B, Ann-Christin B-H, Valli A, Stenvinkel P, Lindholm B, Suliman ME. Modification of the oxidative stress biomarker AOPP assay: application in uremic samples. Clin Chim Acta. 2008;393(2):114?8.
  10. Perez-Padilla R, Vazquez-Garcia JC, Marquez MM, Menezes MA. Spirometry quality-control strategies in a multinational study of the prevalence of chronic obstructive pulmonary disease. Respir Care. 2008;53(8):1019?26.
  11. Goodarzi MT, Abdi M, Tavilani H, Nadi E, Rashidi M. Adenosine deaminase activity in COPD patients and healthy subjects. Iran J Allergy, Asthma Immunol. 2010;9(1):7?12.
  12. Bamonti F, Novembrino C, Ippolito S, Soresi E, Ciani A, Lonati S, et al. Increased free malondialdehyde concentrations in smokers normalise with a mixed fruit and vegetable juice concentrate: a pilot study. Clin Chem Lab Med. 2006;44(4):391?5.
  13. Ranjbar A, Zhad Y, Mirzade HE, Esmaeili A, Ghasemi Nejad S, Maleki Rad A. Comparison of oxidative stress in smokers and non smokers. J Arak Med Sch. 2004;7(3):7?11.
  14. Jaggi S, Yadav AS. Increased serum malondialdehyde levels among cigarette smokers. Pharma Innov J. 2015;4(4):94?6.
  15. Baskol G, Demir H, Baskol M, Kilic E, Ates F, Karakukcu C, et al. Investigation of protein oxidation and lipid peroxidation in patients with rheumatoid arthritis. Cell Biochem Funct. 2006;24(4):307?11.
  16. Pan H-Z, Zhang H, Chang D, Li H, Sui H. The change of oxidative stress products in diabetes mellitus and diabetic retinopathy. Br J Ophthalmol. 2008;92(4):548?51.
  17. Kar K, Sinha S. Correlation between Advanced Oxidation Protein Products ( AOPP ) and Antioxidant status in Type 2 diabetics in Southern Asian Region. Sch J Appl Med Sci. 2014;2(2B):647?52.
  18. Witko-Sarsat V, Friedlander M, Capeill?re-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996;49(5):1304?13.
  19. Witko-Sarsat V, Gausson V, Descamps-Latscha B. Are advanced oxidation protein products potential uremic toxins? Kidney Int. 2003;63(84):11?4.
  20. GOLD - the Global initiative for chronic Obstructive Lung Disease [Internet]. Global Initiative for Chronic Obstructive Lung Disease, Inc. 2016. p. 12?6. Available from: http://www.goldcopd.org/Guidelines/guidelines-resources.html
  21. Bano R, Mahagaonkar AM, Kulkarni NB, Ahmad N, Nighute S. Study of pulmonary function tests among smokers and non-smokers in a rural area. pravara Med Rev. 2009;4(1):11?6.
  22. Hansen JE, Sun X-G, Wasserman K. Spirometric Criteria for Airway Obstruction. Chest. 2007;131(2):349?55.
  23. Kocak H, Gumuslu S, Sahin E, Ceken K, Gocmen YA, Yakupoglu G, et al. Advanced oxidative protein products are independently associated with endothelial function in peritoneal dialysis patients. Nephrology. 2009;14(3):273?80.


Anurag Yadav
Assistant Professor, Department of Bicohemistry, MNR Medical college and Hospital, Sangareddy, Telangana, India


Article DOI: 10.21474/IJAR01/10432       DOI URL: http://dx.doi.org/10.21474/IJAR01/10432

Share this article